CBIO - Catalyst Biosciences, Inc.

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. Estimate-0.07-0.05-0.16-0.15
Low estimate-0.07-0.05-0.16-0.15
High estimate-0.07-0.05-0.16-0.15
Year ago EPS-0.461.64-0.26-0.16
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts1111
Avg. EstimateN/AN/AN/AN/A
Low estimateN/AN/AN/AN/A
High estimateN/AN/AN/AN/A
Year ago salesN/AN/AN/AN/A
Sales growth (year/est)N/AN/AN/AN/A
Earnings history30/03/202229/06/202229/09/202230/03/2023
Est. EPS-0.44-0.24-0.1-0.07
Actual EPS-0.461.64-0.160.01
Difference-0.021.88-0.060.08
Surprise %-4.50%783.30%-60.00%114.30%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.07-0.05-0.16-0.15
7 days ago-0.07-0.05-0.16-0.15
30 days ago-0.06-0.06-0.24-0.13
60 days ago-0.06-0.06-0.15-0.13
90 days ago-0.09-0.09-0.21-0.29
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 daysN/AN/AN/AN/A
Up last 30 daysN/A11N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 daysN/AN/AN/AN/A
Growth estimatesCBIOIndustrySector(s)S&P 500
Current qtr.84.80%N/AN/AN/A
Next qtr.-103.00%N/AN/AN/A
Current year38.50%N/AN/AN/A
Next year6.30%N/AN/AN/A
Next 5 years (per annum)-23.33%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A